Video

How New Antimicrobial Options Could Change Existing Care, Affect Stewardship Programs

J. Russell May, PharmD, FASHP, clinical professor at Georgia Regents University College of Pharmacy, discusses how new antimicrobial options could change existing care and affect stewardship programs.

J. Russell May, PharmD, FASHP, clinical professor at Georgia Regents University College of Pharmacy, discusses how new antimicrobial options could change existing care and affect stewardship programs.

This interview was recorded at the ASHP 2014 Midyear Clinical Meeting in Anaheim, California.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Monoclonal antibodies are used to treat lung cancer. They are created in a lab and designed to target specific proteins on cancer cells, stopping them from growing and dividing.
Gene therapy in lung cancer (LC) - isometric view 3d illustration
© 2025 MJH Life Sciences

All rights reserved.